QuickView for MEF2;jsessionid=A01E3C1909B4452B633F8EC7E8E36577;jsessionid=44CFA76EFB3F1944AE0DD3873AEC8F4E;jsessionid=D4A760663DB14EAF00EE991022904523 (gene)

Summary
General Info

Body Atlas

Most Correlated Tissues

Heart
Heart atrium
Heart ventricle
Skeletal muscle
Synovial membrane

Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

Anthrax
Poisoning by drug AND/OR medicinal substance
Disease due to Adenovirus
General adaptation syndrome
Coronary arteriosclerosis

Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

tris(2,3-dibromopropyl)phosphate
indole
Nonoxynol-9
Organophosphorus Compounds
1-amino-2,4-dibromoanthraquinone

Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

twi
Myod1
Myf5
TPI1
MEF2A

Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Explore Curated Studies Results

Literature

Most Relevant Literature

Evolutionary conserved circular MEF2A RNAs regulate myogenic differentiation and skeletal muscle dev…
Bioinformatics and expression analysis of the Xeroderma Pigmentosum complementation group C (XPC) of…
Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mito…
MiRNA-615-3p Alleviates Oxidative Stress Injury of Human Cardiomyocytes Via PI3K/Akt Signaling by Ta…
Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.

Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

There were no clinical trials for MEF2;jsessionid=A01E3C1909B4452B633F8EC7E8E36577;jsessionid=44CFA76EFB3F1944AE0DD3873AEC8F4E;jsessionid=D4A760663DB14EAF00EE991022904523

Explore Clinical Trials Results